Nancy J Kelley, JD, MPP is a nationally recognized executive who has driven key strategic initiatives in science and medicine for over 20 years. She has a deep understanding of the healthcare, life science and research fields and has in-depth knowledge of the related legal, business, government, non-profit and academic sectors in NYC and across the country.
Ms. Kelley's prior leadership history includes work in scientific institutions, life science companies and life science real estate development. She is a Founding Member of NYC Builds BIO+. She is a member of the Founding Leadership team of the international scientific project GP-write and the associated Center of Excellence for Engineering Biology, and helped to launch the Biodesign Challenge. Ms. Kelley was the Founding Executive Director of the New York Genome Center and a lead executive in the development of the East River Science Park (now, Alexandria Life Science Center) in Manhattan. She has overseen major development projects for clients such as Harvard's McLean Hospital, NIH, Johns Hopkins, and MIT.
Ms. Kelley also acquired years of experience in growing life science companies from start-up through development into established enterprises as a former corporate securities partner at the Boston law firm of Hale and Dorr (now Wilmer Hale).
Ms. Kelley has served on Boards for the New York Genome Center, The Jackson Laboratory, Beth Israel Deaconess Medical Center, and the Whitehead Institute.
She holds an AS from Manchester Community College, a BA from Yale College, a JD from Harvard Law School and an MPP from Harvard Kennedy School. She has been appointed both a White House Fellow and Truman Scholar.
Dr. Evers is recognized as an expert in bioinformatics and DNA sequencing technology with applications in molecular biology and precision medicine. He has been active in biotechnology and science for more than 15 years. He has found a second vocation in project managing the construction of R&D and diagnostic laboratory buildings for pharma and biotech.
Dirk J. Evers received his doctorate at Bielefeld University on algorithms for RNA secondary structure prediction. He started his industry career in Tübingen at Exelixis Deutschland GmbH. He then returned to academia heading the International NRW Graduate School for Bioinformatics and Genome Research at the Centre for Biotechnology of Bielefeld University. As Director of Computational Biology for Illumina Inc. in the UK he joined during the launch of the market leading next generation sequencing technology. He then became one of the first members of the New York Genome Center as SVP Informatics and returned to Germany to join Molecular Health GmbH as VP Data Operations and later SVP Alliance Management. Since 2016 he consults for biotechnology as well as the pharmaceutical and healthcare industries.
Kate McDonough has built her career developing young companies in the biotechnology and software spaces. She focuses on business development and project management at NJK+A. Previously, Kate worked at Hive, a project management software backed by Comcast and based in 1 World Trade, New York City.
Kate started at Hive as a Sales Development Representative. She rose through the ranks to become an Enterprise Account Executive. Kate generated $1M/year worth of revenue. Her client list included Electronic Arts (EA), Anheuser Busch, and Toyota. Before Hive, Kate worked with Dr. Jennifer Elisseeff at the Translational Tissue Engineering Institute at Johns Hopkins. Kate graduated as a Meriwether Lewis Fellow with a B.S. in Biomedical Engineering from the University of Virginia. She also played Varsity Squash and gained her pilot’s license for single engine aircraft.
|cookielawinfo-checkbox-analytics||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".|
|cookielawinfo-checkbox-functional||11 months||The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".|
|cookielawinfo-checkbox-necessary||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".|
|cookielawinfo-checkbox-others||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.|
|cookielawinfo-checkbox-performance||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".|